Total Payments
$10,817
2024 Payments
$223.46
Companies
26
Transactions
56
Medicare Patients
5,659
Medicare Billing
$687,419
Payment Breakdown by Category
Consulting$3,750 (34.7%)
Other$2,850 (26.3%)
Food & Beverage$2,478 (22.9%)
Travel$1,739 (16.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,750 | 1 | 34.7% |
| Food and Beverage | $2,478 | 50 | 22.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,150 | 1 | 19.9% |
| Travel and Lodging | $1,739 | 3 | 16.1% |
| Honoraria | $700.00 | 1 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cardinal Health 200, LLC | $5,211 | 4 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $2,415 | 9 | $0 (2020) |
| Medtronic Vascular, Inc. | $703.65 | 8 | $0 (2018) |
| Cardiac Assist, Inc. | $700.00 | 1 | $0 (2018) |
| Corindus Inc. | $461.00 | 1 | $0 (2018) |
| Abbott Laboratories | $436.21 | 10 | $0 (2022) |
| Boston Scientific Corporation | $177.50 | 1 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $167.84 | 1 | $0 (2018) |
| The Spectranetics Corporation | $82.51 | 1 | $0 (2017) |
| Philips Electronics North America Corporation | $71.89 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $223.46 | 3 | Boston Scientific Corporation ($177.50) |
| 2023 | $176.91 | 5 | Philips Electronics North America Corporation ($71.89) |
| 2022 | $81.77 | 4 | Lantheus Medical Imaging, Inc. ($26.98) |
| 2021 | $51.48 | 2 | Penumbra, Inc. ($26.96) |
| 2020 | $131.11 | 8 | AstraZeneca Pharmaceuticals LP ($41.08) |
| 2019 | $157.34 | 3 | AstraZeneca Pharmaceuticals LP ($157.34) |
| 2018 | $1,614 | 13 | Cardiac Assist, Inc. ($700.00) |
| 2017 | $8,381 | 18 | Cardinal Health 200, LLC ($5,211) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $22.33 | General |
| Category: Endovascular | ||||||
| 05/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $177.50 | General |
| Category: General - Vascular Access_IC | ||||||
| 04/18/2024 | Canon Medical Systems USA, Inc. | INTERVENTIONAL ANGIOGRAPHY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: INFX-8000C | ||||||
| 11/22/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device), ATRICLIP LAA EXCLUSION SYSTEM | Food and Beverage | In-kind items and services | $39.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/21/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/18/2023 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $26.17 | General |
| 01/26/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $71.89 | General |
| Category: Medical Device | ||||||
| 12/05/2022 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $8.86 | General |
| Category: Peripheral Intervention | ||||||
| 08/16/2022 | Abbott Laboratories | XIENCE V (Device) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Vascular | ||||||
| 03/23/2022 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: CONTRAST AGENT | ||||||
| 03/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2021 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/01/2021 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $26.96 | General |
| Category: Peripheral Intervention | ||||||
| 12/30/2020 | Abbott Laboratories | Dragonfly OCT (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/18/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Cardiovascular | ||||||
| 10/07/2020 | Abbott Laboratories | Xience Sierra Coronary Stent System (Device) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/30/2020 | Cook Medical LLC | Cook Medical Angioplasty (Device) | Food and Beverage | Cash or cash equivalent | $18.01 | General |
| Category: Peripheral Intervention | ||||||
| 09/29/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/01/2020 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CONTRAST AGENT | ||||||
| 06/11/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/17/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $131.04 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,734 | 2,188 | $853,296 | $208,387 |
| 2022 | 19 | 1,546 | 1,976 | $726,985 | $177,230 |
| 2021 | 17 | 1,423 | 1,758 | $686,770 | $184,891 |
| 2020 | 17 | 956 | 1,097 | $414,225 | $116,911 |
Total Patients
5,659
Total Services
7,019
Medicare Billing
$687,419
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 259 | 482 | $173,520 | $53,163 | 30.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 147 | 152 | $78,810 | $24,465 | 31.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 375 | 389 | $136,150 | $21,390 | 15.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 111 | 115 | $117,300 | $19,924 | 17.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 191 | $40,115 | $14,105 | 35.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 22 | 24 | $56,400 | $13,592 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 76 | $36,480 | $12,497 | 34.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 93 | 96 | $38,880 | $11,614 | 29.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 47 | 49 | $60,270 | $10,863 | 18.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $26,680 | $8,535 | 32.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 245 | 335 | $33,500 | $4,412 | 13.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $9,790 | $3,168 | 32.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 28 | $8,040 | $3,109 | 38.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 22 | 24 | $6,000 | $1,952 | 32.5% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 22 | 45 | $7,596 | $1,625 | 21.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 24 | 24 | $10,200 | $1,414 | 13.9% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 17 | 17 | $6,375 | $1,208 | 18.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 23 | 23 | $2,070 | $425.22 | 20.5% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 17 | 17 | $2,550 | $405.28 | 15.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 17 | 17 | $1,530 | $339.04 | 22.2% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 16 | 16 | $1,040 | $182.25 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 239 | 435 | $156,600 | $46,858 | 29.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 330 | 336 | $117,600 | $19,494 | 16.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 99 | 104 | $106,080 | $18,042 | 17.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 152 | 165 | $47,025 | $16,204 | 34.5% |
About Dr. John Reilly, MD
Dr. John Reilly, MD is a Cardiovascular Disease healthcare provider based in Southampton, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881640134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Reilly, MD has received a total of $10,817 in payments from pharmaceutical and medical device companies, with $223.46 received in 2024. These payments were reported across 56 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($3,750).
As a Medicare-enrolled provider, Reilly has provided services to 5,659 Medicare beneficiaries, totaling 7,019 services with total Medicare billing of $687,419. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Interventional Cardiology
- Location Southampton, NY
- Active Since 05/26/2006
- Last Updated 09/27/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1881640134
Products in Payments
- BRILINTA (Drug) $2,284
- Resolute (Device) $703.65
- TandemHeart (Device) $700.00
- VIABAHN Endoprosthesis with Heparin Bioactive Surface (Device) $167.84
- Circulatory Support (Device) $130.76
- TURBO POWER (Device) $82.51
- (5091) Amb Mon & Diag Und (Device) $71.89
- AMPLATZER Occluders (Device) $70.53
- Occluders (Device) $55.25
- AMPLATZER Vascular Plugs (Device) $50.69
- BMW guide wires (Device) $46.05
- DEFINITY (Drug) $42.64
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $39.58
- LifeVest (Device) $39.27
- Indigo System (Device) $35.82
- XIENCE V (Device) $26.35
- Barostim Neo System (Device) $24.52
- INTERVENTIONAL ANGIOGRAPHY SYSTEM (Device) $23.63
- PARADISE RENAL DENERVATION SYSTEM (Device) $22.33
- Impella (Device) $21.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.